Brought to you by 
Xomed licenses ENT rights to ArthroCare's coblation
13 Jul 1999
Executive Summary
Ear, nose, and throat (ENT) surgical products company Xomed has acquired exclusive worldwide rights to ArthroCare's coblation technology for the ENT market. The deal covers all ArthroCare ENT products sold under the ENTec brand name.
Deal Industry
- Medical Devices
-
Medical Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Xomed licenses ENT rights to ArthroCare's coblation
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice